A 3-year-old boy from rural Maharashtra presents with recurrent episodes of vomiting, lethargy, and hypoglycemia triggered by fasting or intercurrent illness. Serum lactate is markedly elevated (8 mmol/L; normal <2), and urine organic acids show elevated methylmalonic acid. Genetic testing confirms methylmalonyl-CoA mutase deficiency. The child is currently stable on oral intake. What is the most appropriate immediate next step in management?

Explanation

## Clinical Context: Methylmalonic Aciduria and TCA Cycle Dysfunction Methylmalonic-CoA mutase is a B12-dependent enzyme that catalyzes the conversion of methylmalonyl-CoA → succinyl-CoA, a critical anaplerotic reaction feeding the TCA cycle. Deficiency causes: - Accumulation of methylmalonic acid (organic acidosis) - Impaired TCA cycle flux → hypoglycemia and energy deficit - Risk of acute metabolic decompensation during catabolic stress ## Pathophysiology **Key Point:** Methylmalonic aciduria represents a block in the entry of propionyl-CoA-derived carbons into the TCA cycle. This impairs both energy production and gluconeogenesis, making the patient vulnerable to hypoglycemia and lactic acidosis during fasting or infection. **High-Yield:** The elevated lactate reflects: 1. Shunting of pyruvate away from the TCA cycle (due to reduced succinyl-CoA availability) 2. Increased anaerobic metabolism to compensate for energy deficit 3. Impaired lactate clearance (TCA cycle dysfunction) ## Management Algorithm ```mermaid flowchart TD A[Methylmalonic aciduria diagnosed]:::outcome --> B{Acute symptoms or metabolic decompensation?}:::decision B -->|Yes: hypoglycemia, elevated lactate| C[IV glucose infusion + metabolic stabilization]:::action B -->|No: stable| D[Oral dietary management] C --> E[Urgent metabolic specialist review]:::action E --> F[Protein restriction + B12 supplementation]:::action F --> G[Long-term monitoring of organic acids]:::outcome ``` ## Why This Answer is Correct **Key Point:** The child has biochemical evidence of metabolic decompensation (elevated lactate, hypoglycemia history). The immediate priority is: 1. **Metabolic stabilization:** IV glucose to suppress catabolism and reduce propionyl-CoA generation 2. **Specialist input:** Metabolic disease specialists determine the specific B12 responsiveness and dietary protein targets 3. **Adjunctive therapy:** B12 supplementation (if responsive form) and dietary protein restriction to limit propionyl-CoA precursors **Clinical Pearl:** Even though the child is currently stable on oral intake, the history of recurrent hypoglycemic episodes and documented organic acidosis warrants proactive IV support and specialist review to prevent future crises. ## Why Other Options Are Incorrect | Option | Why Wrong | |--------|----------| | High-dose biotin | Biotin is not a cofactor for methylmalonic-CoA mutase (B12 is). Biotin deficiency causes different organic acidurias (e.g., 3-methylcrotonyl-CoA carboxylase deficiency). Waiting 2 weeks is unsafe given hypoglycemia risk. | | Liver biopsy | Methylmalonic aciduria is a genetic enzyme defect, not a hepatic structural disease. Biopsy does not guide acute management and delays necessary intervention. | | Empirical antibiotics | No clinical or laboratory evidence of infection. Antibiotics do not address the underlying metabolic block and delay definitive management. |